Skip to content

Effects of Acute Exercise on Acetylcarnitine Concentration in Endurance Trained and Untrained Subjects

Effects of Acute Exercise on Acetylcarnitine Concentration in Endurance Trained and Untrained Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01553968
Enrollment
9
Registered
2012-03-14
Start date
2012-04-30
Completion date
2014-06-30
Last updated
2016-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Brief summary

It has been suggested that imbalance between TCA-cycle flux and β-oxidation may underlie insulin resistance, a predisposing factor for the development of type 2 diabetes mellitus. Acetylcarnitine concentration is suggested to be a marker of such imbalance. It is expected that when TCA-cycle capacity is high (a high oxidative capacity), less acetylcarnitine will accumulate, because of an improved balance between supply and demand of lipids. The major research objective is to examine if acute exercise results in a more pronounced increase in acetylcarnitine concentration in sedentary subjects compared to endurance-trained subjects and if the exercise-induced increase in acetylcarnitine is restored more quickly in endurance-trained subjects when compared to sedentary subjects. The investigators hypothesize that the increase in acetylcarnitine levels will be lower in trained subjects when compared to sedentary subjects, due to a better balance between lipid supply and utilization by the TCA-cycle. Furthermore it is expected that acetylcarnitine concentrations will be restored faster in these trained subjects, because of a tighter regulation of influx of fatty acids. To test this hypothesis the investigators want to compare the acetylcarnitine response to exercise in a group of sedentary subjects and a group of endurance trained subjects. This response will be measured for 30 minutes after exercise with the use of 1H-MRS.

Interventions

OTHERCycling

30 minutes of cycling at 50% of predetermined maximal performance

Sponsors

Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Normal weight (BMI 18-25 kg/m2) * Healthy * Stable dietary habits * No use of medication * VO2-max for trained subjects above 50 mL/min/kg * VO2-max for untrained subjects below 40 mL/min/kg

Exclusion criteria

* Any medical condition requiring treatment and/or medication use OR diminishing exercise tolerance * Alcohol consumption of more than 20 g per day (± 2 units) * Unstable body weight (weight gain or loss \> 3 kg in the past three months) * Participation in another biomedical study within 1 month prior to the screening visit * Contraindications for MRI scan: * Central nervous system aneurysm clips * Implanted neural stimulator * Implanted cardiac pacemaker of defibrillator * Cochlear implant * Iron- containing corpora aliena in the eye or brain * Hearing aids and artificial (heart) valves which is contraindicated for MRS * Subjects, who do not want to be informed about unexpected medical findings cannot participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Exercise-induced changes in acetylcarnitine concentrations and dynamics of acetylcarnitine restoration after exerciseDuring 30 minutes prior to the exercise and for 30 minutes after exerciseAcetylcarnitine concentration measured with Proton Magnetic Resonance Spectroscopy (1H-MRS)

Secondary

MeasureTime frameDescription
Substrate oxidationMeasured during the 30 minutes of exerciseMeasured with indirect calorimetry
Blood plasma free fatty acidsAt the start and at the end of 30 minutes of exerciseBlood sample of 10 mL
Blood plasma triglyceridesAt the start and at the end of 30 minutes of exerciseBlood sample of 10 mL
Blood plasma glucoseAt the start and at the end of 30 minutes of exerciseBlood sample of 10 mL

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026